Please login to the form below

Not currently logged in
Email:
Password:

Edward Hodgkin elected chair of UK biotech association

He will take up his new role at the BIA in October

BIA Ed HodgkinThe UK's BioIndustry Association (BIA) has elected Edward Hodgkin to be its new chair, succeeding Tim Edwards.

Hodgkin has been a non-executive director of the BIA since 2010 and currently serves on the Association's executive committee.

His career in pharma and biotech has so far spanned more than 20 years, during which time he has held a variety of scientific, business and management roles in the US and UK.

Hodgkin is currently a partner at the Wellcome Trust's independent subsidiary Syncona Partners, where his role is to create and lead new life science ventures. Prior to that he spent five years at Cambridge therapeutics company Biotica Technology as its CEO. 

He said:
"While our members face many challenges, not least being access to capital, there is a fantastic opportunity to put life sciences at the forefront of the nation's recovering economy. Government, private enterprise and the public sector are aligned in this ambition, and the BIA is playing a central role in facilitating that."

His predecessor, Tim Edwards, served as BIA chair for three years and will remain a member of the Association's board.

Edwards said:
"I am delighted that Ed has been elected as the new chairman of the BIA. His experience in the UK life sciences sector will be of great benefit to the organisation and its members. 

 “The BIA continues to be the leading advocacy group for the UK's innovative bioscience companies of all sizes, and I thank Steve and his team for all their work on behalf of our members."

1st July 2013

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics